Workflow
OraSure Technologies(OSUR)
icon
Search documents
OraSure Technologies(OSUR) - 2023 Q1 - Quarterly Report
2023-05-10 21:00
OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023. Commission File Number 001-16537 ORASURE TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incor ...
OraSure Technologies(OSUR) - 2022 Q4 - Annual Report
2023-03-03 22:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-16537 ORASURE TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-4370966 (State or other jurisdiction ...
OraSure Technologies(OSUR) - 2022 Q4 - Earnings Call Transcript
2023-02-15 03:00
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2022 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Scott Gleason - SVP, IR & Corporate Communications Carrie Manner - President, CEO & Director Kenneth McGrath - CFO Conference Call Participants Vijay Kumar - Evercore ISI Elizabeth Speyer - Citigroup Brandon Couillard - Jefferies Jacob Johnson - Stephens Inc. Casey Woodring - JPMorgan Chase & Co. Andrew Cooper - Raymond James & Associates Operator Good day, and thank you pray. Welcome ...
OraSure Technologies(OSUR) - 2022 Q3 - Earnings Call Transcript
2022-11-09 03:47
OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Scott Gleason - Senior Vice President of Communications and Investor Relations Carrie Manner - President and Chief Executive Officer Kenneth McGrath - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Casey Woodring - JPMorgan Chase & Co. Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies’ Third Quarter Earnings Confere ...
OraSure Technologies(OSUR) - 2022 Q3 - Quarterly Report
2022-11-08 21:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-16537 ORASURE TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of I ...
OraSure Technologies(OSUR) - 2022 Q2 - Earnings Call Transcript
2022-08-10 03:38
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Scott Gleason - Senior Vice President of Investor Relations & Corporate Communications Carrie Manner - President & Chief Executive Officer Kathleen Weber - President of Molecular Solutions Ken McGrath - Chief Financial Officer Lisa Nibauer - President of Diagnostics Conference Call Participants Casey Woodring - JPMorgan Andrew Cooper - Raymond James Operator Welcome to the OraSure Technol ...
OraSure Technologies(OSUR) - 2022 Q2 - Quarterly Report
2022-08-09 20:18
(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-16537 ORASURE TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorp ...
OraSure Technologies(OSUR) - 2022 Q1 - Earnings Call Transcript
2022-05-11 03:33
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Kathleen Weber - President of Molecular Solutions Lisa Nibauer - President of Diagnostics Nancy Gagliano - Interim Chief Executive Officer & Director Scott Gleason - Senior Vice President of Investor Relations & Corporate Communications and Interim Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Chase Andrew Cooper - Raymond James Frank Takkinen - Lake Street ...
OraSure Technologies(OSUR) - 2022 Q1 - Quarterly Report
2022-05-10 20:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-16537 ORASURE TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incor ...
OraSure Technologies(OSUR) - 2021 Q4 - Annual Report
2022-03-01 21:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-16537 ORASURE TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-4370966 (State or other jurisdiction ...